• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于定量测定人血浆中雷贝拉唑的液相色谱/串联质谱分析法的开发。

Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma.

作者信息

Huang Jinchang, Xu Yu, Gao Shu, Rui Lei, Guo Qingxiang

机构信息

Department of Chemistry, University of Science and Technology of China, Hefei 230026, China.

出版信息

Rapid Commun Mass Spectrom. 2005;19(16):2321-4. doi: 10.1002/rcm.2066.

DOI:10.1002/rcm.2066
PMID:16021618
Abstract

A simple and sensitive liquid chromatography/tandem mass spectrometry method, employing electrospray ionization, has been developed and validated to quantify rabeprazole in human plasma using omeprazole as the internal standard. The method was validated to demonstrate the specificity, lower limit of quantification, accuracy, and precision of measurements. Selected reaction monitoring was specific for rabeprazole and omeprazole (the internal standard, IS); no endogenous materials interfered with the analysis of rabeprazole and IS from blank plasma. The assay was linear over the concentration range 0.2-200 ng/mL using a 2 microL aliquot of plasma. The correlation coefficients for the calibration curves ranged from 0.9988-0.9994. The intra- and inter-day precision, calculated from quality control samples, were less than 6.65%. A mixture of methanol and water (50:50) was used as the isocratic mobile phase, with 0.1% of formic acid in water, that did not affect the stability of rabeprazole or IS. A simple sample preparation method of protein precipitation with methanol was chosen. The method was employed in a pharmacokinetic study after oral administration of 20 mg rabeprazole to 24 healthy volunteers.

摘要

已开发并验证了一种采用电喷雾电离的简单且灵敏的液相色谱/串联质谱法,以奥美拉唑为内标定量测定人血浆中的雷贝拉唑。该方法经过验证,以证明测量的特异性、定量下限、准确性和精密度。选择反应监测对雷贝拉唑和奥美拉唑(内标,IS)具有特异性;没有内源性物质干扰空白血浆中雷贝拉唑和内标的分析。使用2微升血浆等分试样,该测定在0.2 - 200纳克/毫升的浓度范围内呈线性。校准曲线的相关系数范围为0.9988 - 0.9994。由质量控制样品计算得出的日内和日间精密度均小于6.65%。甲醇和水(50:50)的混合物用作等度流动相,水中含有0.1%的甲酸,这不会影响雷贝拉唑或内标的稳定性。选择了用甲醇进行蛋白沉淀的简单样品制备方法。该方法用于对24名健康志愿者口服20毫克雷贝拉唑后的药代动力学研究。

相似文献

1
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma.用于定量测定人血浆中雷贝拉唑的液相色谱/串联质谱分析法的开发。
Rapid Commun Mass Spectrom. 2005;19(16):2321-4. doi: 10.1002/rcm.2066.
2
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of lisinopril in human plasma.开发一种用于定量测定人血浆中赖诺普利的液相色谱/串联质谱分析法。
Rapid Commun Mass Spectrom. 2006;20(2):248-52. doi: 10.1002/rcm.2309.
3
High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction.采用固相萃取法测定人血浆中雷贝拉唑含量的高效液相色谱法
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):209-14. doi: 10.1016/j.jchromb.2004.11.032.
4
Quantitative analysis of racecadotril metabolite in human plasma using a liquid chromatography/tandem mass spectrometry.采用液相色谱/串联质谱法对人血浆中消旋卡多曲代谢物进行定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):101-7. doi: 10.1016/j.jchromb.2006.12.041. Epub 2007 Jan 10.
5
Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.高效液相色谱-串联质谱法同时测定人血浆中依那普利和依那普利拉及其在药代动力学研究中的应用
J Pharm Biomed Anal. 2009 Jan 15;49(1):163-7. doi: 10.1016/j.jpba.2008.10.012. Epub 2008 Oct 22.
6
Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma.用于定量测定人血浆中阿奇霉素的灵敏液相色谱/质谱分析法。
Biomed Chromatogr. 2007 Dec;21(12):1272-8. doi: 10.1002/bmc.883.
7
Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study.生物等效性研究中雷贝拉唑测定的直接进样、柱切换液相色谱技术
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):247-54. doi: 10.1016/j.jchromb.2004.09.053.
8
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM00104, a novel antineoplastic agent, in mouse, rat, dog, and human plasma.开发一种液相色谱/串联质谱分析法,用于定量测定新型抗肿瘤药物PM00104在小鼠、大鼠、犬和人血浆中的含量。
Rapid Commun Mass Spectrom. 2005;19(5):689-95. doi: 10.1002/rcm.1848.
9
Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.采用柱切换高效液相色谱法测定人血浆中雷贝拉唑及其活性代谢产物雷贝拉唑硫醚,并将其应用于药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):238-43. doi: 10.1016/j.jchromb.2005.07.027.
10
Quantification of pramipexole in human plasma by liquid chromatography tandem mass spectrometry using tamsulosin as internal standard.以坦索罗辛为内标,采用液相色谱串联质谱法测定人血浆中普拉克索的含量。
Biomed Chromatogr. 2007 Nov;21(11):1151-8. doi: 10.1002/bmc.864.

引用本文的文献

1
Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.质子泵抑制剂剂型的研发:现状、挑战与未来展望
Pharmaceutics. 2022 Sep 25;14(10):2043. doi: 10.3390/pharmaceutics14102043.
2
Development and validation of a high throughput UPLC-MS/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in human plasma.一种用于同时定量测定人血浆中埃索美拉唑、雷贝拉唑和左舒必利的高通量超高效液相色谱-串联质谱法的开发与验证
J Pharm Anal. 2016 Jun;6(3):190-198. doi: 10.1016/j.jpha.2016.01.001. Epub 2016 Jan 8.
3
Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules.
采用质量源于设计方法开发并验证用于测定胶囊中雷贝拉唑和左舒必利的超高效液相色谱法
Sci Pharm. 2014 Jan 16;82(2):307-26. doi: 10.3797/scipharm.1310-17. Print 2014 Apr-Jun.
4
Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation.一种用于测定药物制剂中雷贝拉唑钠工艺相关杂质和降解产物的稳定性指示反相高效液相色谱法的开发与验证
Sci Pharm. 2013 Mar 17;81(3):697-711. doi: 10.3797/scipharm.1301-25. Print 2013 Jul-Sep.
5
Quantitative estimation of itopride hydrochloride and rabeprazole sodium from capsule formulation.从胶囊制剂中对盐酸伊托必利和雷贝拉唑钠进行定量估算。
Indian J Pharm Sci. 2008 Sep;70(5):658-61. doi: 10.4103/0250-474X.45411.
6
Simultaneous HPTLC Determination of Rabeprazole and Itopride Hydrochloride From Their Combined Dosage Form.同时用高效薄层色谱法测定雷贝拉唑和盐酸伊托必利复方制剂中二者的含量。
Indian J Pharm Sci. 2008 May-Jun;70(3):366-8. doi: 10.4103/0250-474X.43004.
7
Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.新型H2受体拮抗剂拉呋替丁对胃酸分泌的抑制作用强于质子泵抑制剂兰索拉唑。
World J Gastroenterol. 2008 Apr 21;14(15):2406-10. doi: 10.3748/wjg.14.2406.
8
Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.兰索拉唑口腔崩解片对CYP2C19广泛代谢者胃内pH值的早期影响。
World J Gastroenterol. 2008 Apr 7;14(13):2049-54. doi: 10.3748/wjg.14.2049.